KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $11.6 billion.

  • Novartis Ag's Cash & Current Investments fell 1369.55% to $11.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.6 billion, marking a year-over-year decrease of 1369.55%. This contributed to the annual value of $11.6 billion for FY2025, which is 1369.55% down from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Cash & Current Investments is $11.6 billion, which was down 1369.55% from $9.6 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Cash & Current Investments registered a high of $6000.3 billion during Q1 2021, and its lowest value of $5.0 billion during Q1 2022.
  • Over the past 5 years, Novartis Ag's median Cash & Current Investments value was $11.4 billion (recorded in 2023), while the average stood at $311.8 billion.
  • Per our database at Business Quant, Novartis Ag's Cash & Current Investments surged by 115158445.3% in 2021 and then tumbled by 9991.61% in 2022.
  • Novartis Ag's Cash & Current Investments (Quarter) stood at $28.3 billion in 2021, then crashed by 33.18% to $18.9 billion in 2022, then plummeted by 54.82% to $8.6 billion in 2023, then surged by 57.36% to $13.5 billion in 2024, then fell by 13.7% to $11.6 billion in 2025.
  • Its Cash & Current Investments stands at $11.6 billion for Q4 2025, versus $9.6 billion for Q3 2025 and $7.0 billion for Q2 2025.